After adjusted by age and gender, the association between rs4758680 of IL-31 and LVEF was shown in Table 4 which revealed that the heterozygote CA was the protect factor for DCM patients whose LVEF was <30% compared with those LVEF was ≥30% (P = 0.042). This evidence concerns the gene IL31 and familial dilated cardiomyopathy.